Press releases
- Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002
- Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders
- Gabather reports initial positive results from the EEG/fMRI target engagement study
Key statistics
As of last trade, Gabather AB (GABA:STO) traded at 1.64, 106.44% above the 52 week low of 0.792 set on Feb 29, 2024.
52-week range
Open | 1.58 |
---|---|
High | 1.64 |
Low | 1.58 |
Bid | 1.45 |
Offer | 1.71 |
Previous close | 1.58 |
Average volume | 26.02k |
---|---|
Shares outstanding | 18.10m |
Free float | 17.30m |
P/E (TTM) | -- |
Market cap | 28.59m SEK |
EPS (TTM) | -0.652 SEK |
Data delayed at least 15 minutes, as of Apr 25 2024 10:00 BST.
More ▼